These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
461 related items for PubMed ID: 8402644
21. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material. Karameris AM, Worthy E, Gorgoulis VG, Quezado M, Anastassiades OT. J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251 [Abstract] [Full Text] [Related]
22. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer]. Fan P, Wu Z, Cha X, Wang X, Wang S. Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):655-7. PubMed ID: 11825490 [Abstract] [Full Text] [Related]
23. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations. Scarpa A, Capelli P, Zamboni G, Oda T, Mukai K, Bonetti F, Martignoni G, Iacono C, Serio G, Hirohashi S. Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992 [Abstract] [Full Text] [Related]
24. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Ohue M, Tomita N, Monden T, Fujita M, Fukunaga M, Takami K, Yana I, Ohnishi T, Enomoto T, Inoue M. Cancer Res; 1994 Sep 01; 54(17):4798-804. PubMed ID: 8062281 [Abstract] [Full Text] [Related]
25. BRCA-associated breast cancer: absence of a characteristic immunophenotype. Robson M, Rajan P, Rosen PP, Gilewski T, Hirschaut Y, Pressman P, Haas B, Norton L, Offit K. Cancer Res; 1998 May 01; 58(9):1839-42. PubMed ID: 9581822 [Abstract] [Full Text] [Related]
26. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy. Turner BC, Gumbs AA, Carbone CJ, Carter D, Glazer PM, Haffty BG. Cancer; 2000 Mar 01; 88(5):1091-8. PubMed ID: 10699900 [Abstract] [Full Text] [Related]
27. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ. Cancer Res; 1993 Jul 01; 53(13):3103-8. PubMed ID: 8319218 [Abstract] [Full Text] [Related]
28. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Oda H, Nakatsuru Y, Ishikawa T. Cancer Res; 1995 Feb 01; 55(3):658-62. PubMed ID: 7834636 [Abstract] [Full Text] [Related]
29. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women. Temmim L, Baker H, Sinowatz F. Anticancer Res; 2001 Feb 01; 21(1B):743-8. PubMed ID: 11299837 [Abstract] [Full Text] [Related]
30. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women. Maruyama N, Miyoshi Y, Taguchi T, Tamaki Y, Monden M, Noguchi S. Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):408-14. PubMed ID: 17202311 [Abstract] [Full Text] [Related]
31. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2. Dabbs DJ. Mod Pathol; 1995 Aug 15; 8(6):637-42. PubMed ID: 8532697 [Abstract] [Full Text] [Related]
32. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P. Breast J; 2005 Aug 15; 11(4):278-80. PubMed ID: 15982396 [Abstract] [Full Text] [Related]
33. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma. Gatalica Z, Lele SM, Rampy BA, Norris BA. Cancer; 2000 Mar 15; 88(6):1378-83. PubMed ID: 10717620 [Abstract] [Full Text] [Related]
34. Cysteine proteinase inhibitor cystatin A in breast cancer. Kuopio T, Kankaanranta A, Jalava P, Kronqvist P, Kotkansalo T, Weber E, Collan Y. Cancer Res; 1998 Feb 01; 58(3):432-6. PubMed ID: 9458085 [Abstract] [Full Text] [Related]
35. Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1. Beck T, Weller EE, Weikel W, Brumm C, Wilkens C, Knapstein PG. Gynecol Oncol; 1995 Apr 01; 57(1):96-104. PubMed ID: 7705708 [Abstract] [Full Text] [Related]
36. Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time. Bukholm IR, Husdal A, Nesland JM, Langerød A, Bukholm G. Breast Cancer Res Treat; 2003 Jul 01; 80(2):199-206. PubMed ID: 12908823 [Abstract] [Full Text] [Related]
37. p53 gene mutations in human urothelial carcinomas: analysis by immunohistochemistry and single-strand conformation polymorphism. Oyasu R, Nan L, Szumel RC, Kawamata H, Hirohashi S. Mod Pathol; 1995 Feb 01; 8(2):170-6. PubMed ID: 7777479 [Abstract] [Full Text] [Related]
38. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ. Mod Pathol; 2003 Jul 01; 16(7):674-8. PubMed ID: 12861063 [Abstract] [Full Text] [Related]
39. Frequent association of p53 gene mutation in invasive bladder cancer. Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T, Terada M. Cancer Res; 1992 Mar 15; 52(6):1393-8. PubMed ID: 1540947 [Abstract] [Full Text] [Related]
40. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors. Kouvaraki M, Gorgoulis VG, Rassidakis GZ, Liodis P, Markopoulos C, Gogas J, Kittas C. Cancer; 2002 May 01; 94(9):2454-65. PubMed ID: 12015771 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]